Combinatorx, Incorporated - Common (MM) News - CRXX

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...

CombinatoRx Reports Financial Results for the Second Quarter 2010

CombinatoRx, Incorporated (NASDAQ: CRXX) today reported financial results for the second quarter ended June 30, 2010. “With...

- Proxy Statement (definitive) (DEF 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement...

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement...

CombinatoRx Set to Join the Russell 3000 Index

CombinatoRx, Incorporated (NASDAQ: CRXX) announced today that it is set to join the broad-market Russell 3000® Index when Russell...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...

CombinatoRx Receives Milestone Payment for Prednisporin Advancement

CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it has received a milestone payment from Fovea Pharmaceuticals, a...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...

CombinatoRx Announces Date of Its 2010 Annual Meeting of Stockholders

CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it currently plans to hold its 2010 Annual Meeting of Stockholders...

CombinatoRx to Present at the Noble Financial Sixth Annual Equity Conference

CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that Mark Corrigan, President and CEO is scheduled to present at the...

- Quarterly Report (10-Q)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d...

CombinatoRx Reports Financial Results for the First Quarter 2010

CombinatoRx, Incorporated (NASDAQ: CRXX) today reported financial results for the first quarter ended March 31, 2010. “In...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Combinatorx, Incorporated - Common (MM) (CRXX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CRXX News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

- Quarterly Report (10-Q)

- Current report filing (8-K)

CombinatoRx Reports Financial Results for the Second Quarter 2010

- Proxy Statement (definitive) (DEF 14A)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

CombinatoRx Set to Join the Russell 3000 Index

- Current report filing (8-K)

CombinatoRx Receives Milestone Payment for Prednisporin Advancement

- Current report filing (8-K)

CombinatoRx Announces Date of Its 2010 Annual Meeting of Stockholders

CombinatoRx to Present at the Noble Financial Sixth Annual Equity Conference

- Quarterly Report (10-Q)

- Current report filing (8-K)

CombinatoRx Reports Financial Results for the First Quarter 2010

CRXX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Combinatorx, Incorporated - Common (MM) (CRXX) News

Combinatorx, Incorporated - Common (MM) (CRXX)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CRXX News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

- Quarterly Report (10-Q)

- Current report filing (8-K)

CombinatoRx Reports Financial Results for the Second Quarter 2010

- Proxy Statement (definitive) (DEF 14A)

- Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)

CombinatoRx Set to Join the Russell 3000 Index

- Current report filing (8-K)

CombinatoRx Receives Milestone Payment for Prednisporin Advancement

- Current report filing (8-K)

CombinatoRx Announces Date of Its 2010 Annual Meeting of Stockholders

CombinatoRx to Present at the Noble Financial Sixth Annual Equity Conference

- Quarterly Report (10-Q)

- Current report filing (8-K)

CombinatoRx Reports Financial Results for the First Quarter 2010

CRXX Discussion

Your Recent History